Skip to content

The nutritional, cardiovascular and immunological effect of daily subcutaneous ghrelin in dialysis patients with evidence of malnutrition

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN43319045
Enrollment
20
Registered
2006-06-22
Start date
2006-03-13
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malnutrition or renal failure Nutritional, Metabolic, Endocrine Malnutrition, kidney failure

Interventions

Subcutaneous ghrelin versus placebo

Sponsors

Hammersmith Hospitals NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Dialysis patients at West London Renal and Transplant Centre, Hammersmith Hospital with evidence of malnutrition

Exclusion criteria

Exclusion criteria: 1. Anaemia 2. Over 75 years of age 3. Recent illness

Design outcomes

Primary

MeasureTime frame
1. Blood pressure 2. Energy expenditure 3. Cytokine production

Secondary

MeasureTime frame
1. Food intake 2. Nutritional parameters

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026